Fidia Pharma Middle East
Wholly owned subsidiary in the Middle East region.
The Dubai subsidiary will also provide field support to Fidia farmaceutici’s customers and distributors in the region more thoroughly and effectively, to ensure they receive the highest quality service.
Fidia Pharma Middle East was formally inaugurated on December 1st, 2015 and employs highly professional and dedicated people, with a diversified product portfolio focusing on hyaluronic acid, with specialization in intra-articular Joint Care, Wound Care and Aesthetic Medicine.
The completion of this project further demonstrates Fidia’s transition into a truly global business, and strategic investment into key emerging markets, such as the Middle East.